Despite these limitations, our findings underscore the critical role of osmotic stress tolerance in cancer cell behavior and support the need for further exploration of NFAT5 and related osmo-adaptive pathways as potential therapeutic targets. The gene discussed is NFAT5; the disease is cancer.